首页 > 抗体蛋白 > 抗体
PE/Cyanine7 anti-T-bet Antibody
产品名称:
PE/Cyanine7 anti-T-bet Antibody
产品类别:
抗体
产品编号:
644823
产品应用:
644823
[价格]
规格 价格 库存
25µg ¥ 2052 1

产品详情

Product Details

Verified Reactivity
Human, Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

ICFC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by intracellular immunofluorescent staining using our?True-Nuclear? Transcription Factor Staining Protocol. For flow cytometric staining, the suggested use of this reagent is ≤0.25 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation2 and immunofluorescence microscopy3.

NOTE: For flow cytometric staining with this clone, True-Nuclear? Transcription Factor Buffer Set (Cat. No. 424401) offers improved staining and is highly recommended over the Foxp3 Fix/Perm Buffer Set (Cat. No. 421403) and the Nuclear Factor Fixation and Permeabilization Buffer Set (Cat. No. 422601).

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Szabo SJ, et al. 2000. Cell 100:655. (ICFC, WB)
  2. Hwang ES, et al. 2005. J. Exp. Med. 202:1289. (ICFC, WB, IP)
  3. Neurath MF, et al. 2002. J. Exp. Med. 195:1129. (IF)
  4. Hsieh CY, et al. 2012. J Pharmacol Exp. 343:125. PubMed.
Product Citations
  1. Harsha Krovi S, et al. 2020. Nat Commun. 4.790277778. PubMed
  2. Wilfahrt D, et al. 2021. Elife. 10:. PubMed
  3. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  4. Trittel S, et al. 2019. Sci Rep. 9:16362. PubMed
  5. Marques RM, et al. 2021. Cell Death Differ. 28:3140. PubMed
  6. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  7. Krueger PD, et al. 2021. Immunity. 54(4):687-701.e4. PubMed
  8. Andrews SF et al. 2019. Immunity. 51(2):398-410 . PubMed
  9. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  10. Baranek T, et al. 2020. Cell Reports. 32(10):108116. PubMed
  11. Elsner RA, et al. 2020. Cell Reports. 29(9):2796-2809.e5.. PubMed
  12. Hong MJ, et al. 2018. Mucosal Immunol. 11:894. PubMed
  13. Ly A, et al. 2020. Cell Reports. 29(8):2257-2269.e6.. PubMed
  14. Rodda LB, et al. 2020. Cell. 184(1):169-183.e17. PubMed
  15. Russler-Germain EV, et al. 2021. Elife. 10:. PubMed
  16. Yang R, et al. 2020. Cell. 183(7):1826-1847.e31. PubMed
  17. Silver J, et al. 2020. Methods Mol Biol. 2121:115. PubMed
  18. Sasaki T, et al. 2020. Cell Reports. 28(1):202-217.e7.. PubMed
  19. Kaya B, et al. 2020. Cell Reports. 32(5):107979. PubMed
  20. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  21. Borges da Silva H, et al. 2020. Immunity. 53(1):158-171.e6. PubMed
  22. Sokal A, et al. 2021. Cell. 184(5):1201-1213.e14. PubMed
  23. Sjaastad FV, et al. 2020. Front Immunol. 11:1786. PubMed
  24. Bhattacharya P, et al. 2020. Elife. 9:00. PubMed
  25. Joubert IA, et al. 2020. Vaccine. 38:1015. PubMed
  26. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  27. Hernndez DC, et al. 2021. Immunity. :. PubMed
  28. Herati RS, et al. 2022. Nat Immunol. 23:1183. PubMed
  29. Csomós K, et al. 2022. Nat Immunol. 23:1256. PubMed
  30. Gaylo‐Moynihan A et al. 2019. Immunity. 51(2):298-309 . PubMed
  31. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  32. Franchini DM et al. 2019. Cell reports. 26(1):94-107 . PubMed
  33. Lamichhane R et al. 2019. Cell Rep. 28(12):3061-3076 . PubMed
  34. Tsai S, et al. 2018. Cell Metab. 28:922. PubMed
RRID
AB_2561760 (BioLegend Cat. No. 644823) AB_2561761 (BioLegend Cat. No. 644824)

Antigen Details

Structure
T-box transcription factor, approximately 58 kD.
Distribution

Nuclear; expressed in T cells, hematopoietic stem cells, NK cells, B cells, lung, spleen.

Function
Th1-specific T-box transcription factor controlling expression of the hallmark Th1 cytokine, interferon gamma (IFN-γ). T-bet expression is critical for the control of microbial pathogens.
Cell Type
B cells, Hematopoietic stem and progenitors, NK cells, T cells, Tregs
Biology Area
Cell Biology, Immunology, Transcription Factors
Molecular Family
Nuclear Markers
Antigen References

1. Szabo SJ, et al. 2000. Cell 100:655.
2. Szabo SJ, et al. 2002. Science 295:338.
3. Finotto S, et al. 2002. Science 295:336.
4. Mullen AC, et al. 2001. Science 292:1907.

Gene ID
30009 View all products for this Gene ID
UniProt
View information about T-bet on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线